45 reports

  • Denmark healthcare providers sector geography segmentation: $ billion, 2019
  • Forces driving competition in the healthcare providers sector in Denmark, 2019

Table ##: Denmark healthcare providers sector value: $ billion, 2015-## Figure ##: Denmark healthcare providers sector value: $ billion, 2015-## ##.

  • Health Care Provider
  • Healthcare
  • Denmark
  • Market Size
  • Roche Group

It additionally explores the level and growth of expenditure on healthcare, new drugs and ongoing research studies.

  • Healthcare
  • Pharmaceutical
  • Denmark
  • Demand
  • Market Size
  • ICT MARKET OPPORTUNITY IN THE HEALTH CARE SECTOR BY SEGMENT: ENTERPRISE FIXED LINE
  • ICT MARKET OPPORTUNITY IN THE HEALTH CARE SECTOR BY SEGMENT: NETWORK SERVICES, USD

Within the body of this report Kable present the market size and forecast spending trends for the sector which covers: TABLE ##: CATEGORY DEFINITIONS Domain Category Definition cards are now almost always built into PCs as a standard.

  • Healthcare
  • ICT
  • Denmark
  • Market Segment
  • Market Size

TABLE ## TABLE ## TABLE ## IDC MATURITYSCAPE: CLOUD IN HEALTHCARE - OVERVIEW OF STAGES, DIMENSIONS, AND SUB-DIMENSIONS Dimensions/ Sub-Dimensions Stage Names Ad hoc Managed Optimized Opportunistic Repeatable The key sub-dimensions are described and elaborated in

  • Advanced IT
  • Cloud Computing
  • Healthcare
  • Denmark
  • World

TABLE ## IDC PLANSCAPE: LEGACY APPLICATION KEY STAKEHOLDERS TABLE ## IDC PLANSCAPE: LEGACY APPLICATION KEY STAKEHOLDERS HOW CAN MY ORGANIZATION TAKE ADVANTAGE OF LEGACY APPLICATION MANAGEMENT IN HEALTHCARE?

  • Application
  • Healthcare
  • ICT
  • Denmark
  • Demand
  • Practice 4: Evaluate Innovation Initiatives Based on Clinical Evidence
  • Practice 3: Engage in Innovation Partnerships Between Providers and Vendors

Within these facilities, ##:## scale models/ mockups of hospital units can be tested and optimized before construction.

  • Health Services
  • Healthcare
  • Hospital
  • Denmark
  • Europe
  • IOT HEALTHCARE USAGE
  • IOT HEALTHCARE USAGE

However, it is important that each hospital executive assesses its internal readiness before defining a specific IoT investment road map. n = ## (hospitals = ##, other healthcare providers = ##) Source: IDC Health Insights, 2015 IOT USAGE SCENARIOS ROAD MAP TABLE ## IOT

  • Advanced IT
  • Healthcare
  • Internet Of Things
  • Denmark
  • Market Size

GlobalData Symphogen A/ S, reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Healthcare
  • Medical Biotechnology
  • Denmark
  • Company
  • Symphogen A/S

GlobalData Region Europe Asia-Pacific Middle East and Africa North America South and Central America No. of Deals ## ## ## ## ## Deal Value (US$ million) ##. ## NA NA NA NA ONCOLOGY VENTURE APS, PHARMACEUTICALS & HEALTHCARE, DEALS BY THERAPY AREA, 2012 TO YT

  • Breast Cancer
  • Healthcare
  • Oncology
  • Denmark
  • Company
  • HEALTHCARE SYSTEM
  • HEALTHCARE FUNDING

Healthcare visits are free-of-charge for patients with Group ## public health insurance, while patients who opt for Group ## are required to contribute to the cost of consultations (see ' Healthcare System: Provision & Funding' ).

  • Healthcare
  • Pharmaceutical
  • Pharmacy
  • Denmark
  • Demand

GlobalData Dako A/ S' s, deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Pharmaceutical
  • Denmark
  • United States
  • M&A

GlobalData Xellia Pharmaceuticals ApS, reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Healthcare
  • Pharmaceutical
  • Denmark
  • Company Operations
  • Deals & Alliance

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Denmark

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Denmark
  • Aarhus University, Pharmaceuticals & Healthcare, Deal Details
  • Aarhus University, Pharmaceuticals & Healthcare, Deal Details

GlobalData Aarhus University' s, deal volume increased from zero pharmaceuticals & healthcare deals in 2016 to one pharmaceuticals & healthcare deal in 2017.

  • Healthcare
  • Pharmaceutical
  • Psychotic Disorder
  • Denmark
  • Deals & Alliance
  • University of Copenhagen, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018
  • University of Copenhagen, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

GlobalData University of Copenhagen' s, deal volume increased from one pharmaceuticals & healthcare deal in 2016 to two pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Vaccine
  • Denmark

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Denmark
  • Galecto Biotech AB, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

GlobalData Galecto Biotech AB, reported one pharmaceuticals & healthcare deal worth $## million in YTD 2018.

  • Biotechnology
  • Healthcare
  • Pharmaceutical
  • Denmark
  • United States

GlobalData IO Biotech ApS, reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Biotechnology
  • Healthcare
  • Denmark
  • Company
  • Deals & Alliance

GlobalData Fertin Pharma A/ S' s, deal volume increased from one pharmaceuticals & healthcare deal in 2016 to two pharmaceuticals & healthcare deals in 2017.

  • Gum
  • Healthcare
  • Pharmaceutical
  • Denmark
  • Deals & Alliance

Summary for the three-month and six-month period ended ## December 2017 Feb ##, 2018: Nuevolution announces its year-end report for 2017 and report for the threemonth period ended ## December 2017 ## October - ## December 2017: Revenue amounted to SEK ##. ## million (##. ##). ## July - ##

  • Drug Development
  • Healthcare
  • Pharmaceutical
  • Denmark
  • Company
  • Exiqon AS, Pharmaceuticals & Healthcare, Deal Details
  • Exiqon AS, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018

GlobalData Exiqon AS' s, deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Diagnostics
  • Healthcare
  • Denmark
  • Deals & Alliance
  • QIAGEN N.V.
  • Technical University of Denmark, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018
  • Technical University of Denmark, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018

GlobalData Technical University of Denmark, reported one pharmaceuticals & healthcare deal each in 2016 and 2017.

  • Healthcare
  • Pharmaceutical
  • Therapy
  • Denmark
  • Deals & Alliance

GlobalData Orphazyme A/ S reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Healthcare
  • Mental Health
  • Denmark
  • Company
  • Centogene AG

The driving force behind the need for rapid reporting of microbiological test results is the clinical relevance in a time of financial austerity, a time when cost and health care effectiveness to the patient and diagnostician looms ever larger, and where after-the-fact results at high expen

  • Healthcare
  • Infectious Disease
  • Pathology
  • Denmark

GlobalData Nuevolution A/ S' s, deal volume decreased from one pharmaceuticals & healthcare deal in 2016 to zero pharmaceuticals & healthcare deals in 2017.

  • Healthcare
  • Pharmaceutical
  • Denmark
  • Company
  • NUEvOLUTION A/S

GlobalData Orphazyme A/ S reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Healthcare
  • Mental Health
  • Denmark
  • Company
  • Centogene AG

GlobalData Orphazyme A/ S reported one pharmaceuticals & healthcare deal in YTD 2018.

  • Healthcare
  • Mental Health
  • Denmark
  • Company
  • Centogene AG
  • ONCONOX APS, PHARMACEUTICALS & HEALTHCARE, DEALS SUMMARY, 2011 TO YTD 2017

GlobalData OncoNOx ApS' s, deal volume increased from zero pharmaceuticals & healthcare deals in 2015 to one pharmaceuticals & healthcare deal in 2016.

  • Healthcare
  • Medical Biotechnology
  • Pharmaceutical
  • Denmark
  • Deals & Alliance
  • ADENIUM BIOTECH APS, PHARMACEUTICALS & HEALTHCARE, DEAL DETAILS

GlobalData is one of the world' s leading providers of company operational data and strategic analysis, providing detailed information on tens of thousands of companies globally.

  • Healthcare
  • Pathology
  • Therapy
  • Denmark
  • Deals & Alliance